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Using a computer program designed to detect evolutionary relationships between proteins, I find that resi- 
dues 72-l 10 of the mature sequence of human tissue-type plasminogen activator (t-PA) and 39 residues 
at the carboxy terminus of human albumin have a comparison score that is 8.8 standard deviation units 
higher than that obtained with a comparison of randomized sequences of these proteins. The probability 
@) of getting this score by chance is _ lo-is, indicating that part of t-PA and albumin are derived from a 
common ancestor. I also find that alpha-fetoprotein, a relative of albumin is related to t-PA. Part of this 
region on t-PA has been previously shown to be related to epidermal growth factor. t-PA, albumin, alpha- 
fetoprotein, and epidermal growth factor have diverse biological activites. The finding that these proteins 
are related suggests ome new approaches for studying their functions. 
Tissue-type plasminogen activator Albumin Alpha-fetoprotein Epidermal growth factor Protein evolution 
1. INTRODUCTION 2. METHODS 
Human tissue-type plasminogen activator (t-PA) 
is a serine protease that is part of the enzymatic 
system for dissolving fibrinogen in blood clots 
[l-3]. Rat and mouse alpha-fetoprotein (AFP) are 
estrogen binding proteins (& -1 nM) [4-71 that 
are related to serum albumin [8-131. Because I 
have been interested in a possible relationship bet- 
ween alpha-fetoprotein and serine proteases 
[ 14- 161, I compared the amino acid sequence of t- 
PA [17] with those of AFP and albumin using 
computer programs developed at the National 
Biomedical Research Foundation for studying 
relationships between proteins [ 18-221. Here, I 
present evidence that 39 residues of t-PA are 
related to a segment at the carboxy terminus of 
albumin and AFP. These residues in t-PA overlap 
with an amino acid sequence that Banyai et al. [23] 
have shown is related to epidermal growth factor 
(EGF) [24-281. These finding suggest some novel 
approaches for understanding the functions of 
these proteins. 
As described by Barker and Dayhoff [22], the 
Relate program compares all possible segments of 
a given length (in this instance 20 amino acids) 
from one sequence with all segments of the same 
length from a second sequence. A segment score is 
accumulated from the pair scores of the amino 
acids occupying corresponding positions with the 
two segments. The pair scores are specified using 
an empirically derived mutation data matrix 
[ 18-221. The mean of a number of highest scores 
is determined for the given sequences and for 250 
comparisons of random permutations of the se- 
quences . The segment comparison score is 
calculated as the difference between the mean of 
the real sequence and the average value determined 
from the randomized sequences divided by the 
standard deviations (SD) of the values from the 
randomized sequences. The segment comparison 
score is thus expressed in SD units. It is assumed 
that a score > 5 SD units (p < 2.8 x lo-‘) indicates 
evolutionary relatedness of two proteins and scores 
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between 3 SD (p < 10m3) and 5 SD 0, < 2.8 x lo-‘) 
support relationship if there are other indications 
such as similarity of function. 
3. RESULTS AND DISCUSSION 
The tripartite structure of albumin and AFP 
suggested the protocol for comparing these pro- 
teins with t-PA. Albumin’s -590 amino acid 
residues consist of 3 homologous domains of 
about 190 amino acid residues each, which Brown 
has proposed evolved by gene duplication from a 
-190 residue primordial domain [29-321. Brown 
also proposed that this -190 residue primordial 
domain itself appeared to have arisen by gene 
duplication from a primordial subdomain of about 
77 amino acid residues. The structure of the genes 
for albumin [33] and AFP [34] supports the main 
points of Brown’s hypothesis. Based on that infor- 
mation, I used the Relate computer program to 
compare the 3 domains of human, bovine, and rat 
albumin and human, rat, and mouse AFP with the 
entire sequence of t-PA. The analysis indicated 
that residues 72- 110 of the mature t-PA sequence 
were related to albumin and AFP, Table I shows 
the results of the Relate analysis comparing 
residues 72-l 10 of t-PA and the 3 domains of the 
different albumins and AFPs. All 3 domains in 
albumin and rat AFP and 2 of the domains in 
mouse and human AFP showed a statistically 
significant comparison score (>3 SD units) with 
residues 72-110 of human t-PA. The highest 
scores are found in the comparison with the third 
domain of albumin and AFP. These scores, which 
range from 5.7 SD (p - 10p8) to 8.8 SD @ - 
IO-“), indicate that these proteins are related. The 
alignment between residues 72-l 10 of t-PA and 
residues 552-590 of the mature sequence of human 
albumin and residues 548-586 of the mature se- 
quence of mouse alpha-fetoprotein presented in 
fig.1 shows that 3 cysteines are aligned in all 3 pro- 
teins and that there are several identities and con- 
servative substitutions in these segments. 
The last 39 residues of domain III of albumin 
and AFP, which have the 8.8 SD comparison score 
with residues 72-110 of human t-PA, comprise 
half of exon L(albumin) 1331 or exon C(AFP) f34] 
and all of exon ~(albumin) or exon D(AFP), Do- 
main III is thought to be most closely related to the 
primordial domain that duplicated twice about 
500-700 million years ago to form the -590 
residue albumin structure that we see today. Fur- 
thermore, these exons contain a 6 or 9 residue se- 
quence [12,35] that is hypothesized to have 
duplicated several times to form the primordial 
-77 residue subdomain about IO9 years ago. 
There are also chemical similarities between 
albumin, AFP, and serine proteases. The most 
notable one comes from Shaw’s studies, which 
were reported in 1963, that DFP reacted with a 
tyrosine residue (later identified as Tyr 411) on 
human serum albumin [36,37]. Also, several 
Table I 
Segment comparison scores of albumin and ~pha-fetoprotein with human tissue-type plasminogen activator 
Plasminogen activator (residues 72-l 10) compared with: 
Domain 1 Domain II Domain III 
Score P Score P Score P 
(SD units) (SD units) (SD units) 
Rat albumin 3.5 -io-3 4.5 -3.5 x 10-6 5.7 -10-s 
Bovine albumin 4.1 -3 x 10-5 3.2 -10-3 6.7 -lo-” 
Human albumin 3.2 -1o-3 3.6 - 1o-4 8.8 _10-‘8 
Mouse AFP 3.9 -5 x 10-5 1.8 _ 5.9 -5 x 1o-9 
Rat AFP 3.5 -1o-3 3.6 -1o-4 5.7 -10-R 
Human AFP 4.1 -3 x 10-5 1.1 _ 6.5 -5 x 10-l’ 
These segment comparison scores were obtained using the Relate program (segment length 20 amino acids) and 250 
random permutations of the sequences for statistical analysis 
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- l&s + Gin - Cys - Pm 
Ser - Tyr 
lys * lau 
Lys - leu 
- Mu -:s;;t- Gly 
L-J 
Fig. 1. Alignment of residues 72-l 10 of human tissue-type plasminogen activator and residues 552-590 of human 
albumin and 548-586 of mouse alpha-fetoprotein. Residue numbering refers to the mature sequence of these proteins. 
Solid boxes show identities and the dotted boxes show readily accepted conservative substitutions. 
studies have established that albumin weakly 
catalyzes the hydrolysis of ester substrates [38-411. 
Means and Wu [42] showed that the site on 
albumin that reacts with DFP also hydrolyzes p- 
nitrophenyl acetate. All of the above suggests that 
albumin has some chemical properties in common 
with serine proteases except that in albumin it is a 
nucleophihc hydroxyl on a tyrosine instead of on 
a serine that reacts with DFP. Like albumin, rat 
AFP forms a covalent adduct with [3H]DFP (un- 
published results). Moreover, AFP has high affini- 
ty for p-nitrophenyl esters 1151. 
Of relevance to the findings reported in table 1 
and fig.1 is the report by Banyai et al. [23] that 
Table 2 
Segment comparison scores of human tissue-type 
plasminogen activator with epidermal growth factors 
Piasminogen activator 
(residues 43-95) with: 
Score P 
(SD units) 
Human EGF 5.8 < lo-* 
Mouse EGF 6.8 <lo-” 
Rat transforming 
growth factor 2.4 -6 x 10-3 
These segment comparison scores were obtained using 
the Relate program (segment length 20 amino acids) and 
250 random permutations of the sequences for statistical 
analysis 
residues 41-91 of t-PA are related to epidermal 
growth factor. Using the Relate computer pro- 
gram, I have quantifid their finding (table 2). The 
segment on t-PA that is related to albumin and 
AFP overlaps the segment on t-PA that is related 
to EGF, which raises some interesting questions 
about the evolution and function(s) of these pro- 
teins. First, do these proteins derive from a com- 
mon ancestor? And, second, do these proteins 
share some biological activities? 
The evolution of proteins by successive duplica- 
tions of a small primordial protein-encoding se- 
quence, which bears on the first question, has been 
discussed in detail by Ohno [12,44-461. All of 
these proteins contain regions that appear to have 
been formed by several duplications of a small 
building block. This process is clearly evident in 
albumin and AFP, where it appears that the entire 
590 amino acid residue sequence of albumin and 
AFP formed from a building block of 77 residues, 
which itself is thought to have formed by suc- 
cessive duplications of a 6 or 9 residue building 
block. The -1175 residue mouse EGF sequence 
contains several -40 residue repeating units [26,27] 
suggesting that a substantial part of mouse EGF 
formed by several duplications of a 40 residue unit 
[28]; and the kringle containing region of t-PA 
(part of which overlaps residues 72-110) has 
duplicated in t-PA [17] as well as in plasmin and 
thrombin [43,47]. 
The computer-based evidence for relatedness 
between parts of albumin, AFP, human t-PA, and 
49 
Volume 182, number 1 FEBS LETTERS March 1985 
mouse EGF presented here and elsewhere; the 
evidence that substantial parts of these proteins 
formed by duplication of a primordial building 
block; and the likelihood that the age of the 
primordial protein-encoding sequence for albumin 
is greater than lo9 years suggests that parts of these 
proteins evolved from a common ancestral gene. 
To obtain a biological benchmark for discussing 
the possibility that these proteins share biological 
activities, I used the Relate program to compare 
mouse EGF, human EGF, and ‘EGF-like’ rat 
transforming growth factor [48-501 with each 
other (table 3). The comparison score of 19.2 SD 
for mouse and human EGF is what would be ex- 
pected for closely related proteins. The com- 
parison of rat transforming growth factor with 
human EGF (8.2 SD) and mouse EGF (6.3 SD) in- 
dicates a more distant relationship. (These com- 
parison scores are in agreement with those using 
the Align analysis [48] .) The biological importance 
of these comparisons is that even with substantial 
divergence from a putative common ancestor of 
mouse and human EGF, rat transforming growth 
factor can bind to EGF receptors with high affinity 
[49] as well as elicit an EGF-like response in cells 
with EGF receptors [50]. This finding is very in- 
teresting because there are no identities between 
residues 21-30 of mouse EGF and rat transform- 
ing growth factor [48,49], where the receptor bind- 
ing domain of mouse EGF exists [51]. Evidently, 
there is sufficient chemical similarity in this region 
Table 3 
Epidermal growth factor family comparisons 
Human Mouse Rat 
EGF EGF trans- 
forming 
growth 
factor 
Human EGF _ 19.2 SD 8.2 SD 
Mouse EGF _ 6.3 SD 
Rat transforming 
growth factor _ 
These segment comparison scores were obtained using 
the Relate program (segment length 20 amino acids) and 
250 random permutations of the sequences for statistical 
analysis 
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and/or information in the rest of rat transforming 
growth factor to permit it to bind to the EGF 
receptor and to be biologically active. Since the 
Relate score of 8.8 SD for the comparison of do- 
main III of human albumin with residues 72-l 10 
of t-PA is equal to or greater than the Relate com- 
parison scores for rat transforming growth factor 
with human and mouse EGF, it is possible that t- 
PA shares some biological activities with albumin 
and AFP. 
Albumin and AFP bind and/or transport fatty 
acids, bilirubin, steroids, and a variety of small 
ligands [30,31,52-541. It will be interesting to 
know if these ligands affect the actions of t-PA, 
and also the actions of mouse EGF in view of the 
amino acid sequence relatedness of t-PA with this 
protein. 
The biological functions of t-PA either in 
dissolving clots or in influencing the growth of 
transformed cells [55-571 depend on its proteolytic 
activity. At this time there is no evidence for a 
biological role for the esterolytic activity of 
albumin. However, because of albumin and AFP’s 
high concentration in serum, it is possible that even 
with low catalytic activity, they could have an en- 
zymatic function. Of course, the assays used thus 
far may not be measuring albumin and AFP’s true 
catalytic activity. Higher catalytic activity may re- 
quire different substrates, the presence of metals 
ions, limited proteolysis, chemical modification 
(e.g., phosphorylation), cofactors such as pyridox- 
al phosphate, etc. 
Alternatively, albumin and AFP may have func- 
tions that depend on the binding of, but not the 
hydrolysis of proteins [58], more like EGF and the 
kringle region of plasmin [47,59,60]. There is sup- 
port for this possibility, first from the report by 
Weisiger et al. [61] of an albumin receptor on liver 
cell membranes, which may mediate the uptake of 
fatty acids, and second from the report by 
Villacampa et al. [62] of a membrane receptor for 
AFP on human MCF-7 breast cancer cells. 
Thus, the computer-based evidence for a com- 
mon ancestor for albumin, alpha-fetoprotein, and 
human tissue-type plasminogen activator present- 
ed here, combined with other studies indicating 
that tissue-type plasminogen activator is related to 
mouse and human epidermal growth factors 1231 
suggests ome new avenues of research for under- 
standing the functioning of these proteins. 
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